Money is dear to all, earning money is
one thing and thinking then where to invest is another. Now the best option to
invest your money is the private equity. There returns are high for the
investors. Quadria Capital is a private healthcare equity firms with assets over 1.5 billion dollars and investing across 18
different countries across Asia- Pacific region.
Quadria Capital is currently the largest equity firms in Asia but their main aim is to partner with promising regional healthcare
companies and, with our active investment strategy, help them grow as regional
leaders and create outstanding returns to the investors. By this way we are
able to benefit both the investors and society. With investing in healthcare we
are able to change the conditions of healthcare facilities in various
countries.
Our approach has always been to find the
promising regional healthcare companies within Asia, because over the past decade
the global hub for healthcare is been shifting to Asia. Before investing in any
regional company we first try to understand the local and regional fundamentals
of healthcare industry in that country. The main is to have meaningful and
sustainable impact on the life and side by side creating values to the
investors.
The firm has invested in India by partnering with leading healthcare
group to benefits the life of the people and creating value to itself and its
investors. The various partners are:
·
Krishna Institute of Medical Science Ltd.
·
Healthcare at Home India
·
Healthcare Global Enterprises Ltd.
·
Krishna Institute of Medical Science
·
Medical Superspeciality Hospital
·
Asian Institute Of Gastroentrology
Apart from investing within India the
company has gone global by partnering with leading diagnostic provide in Malaysia. The partnership will also allow Quadria Capital to support
Lablink’s growth in the Malaysian market and its diversification across Southeast
Asia. With over 400 service
staff, Lablink offers high quality diagnostic services through operating its
central laboratory, as well as managing the hospital laboratories for KPJ Group
hospitals. Its comprehensive service offerings include haematology, chemical
pathology, immunology & serology, histology, biosafety &
mycobacteriology, medical microbiology, cytology, molecular diagnostics, and
health screening packages.
Apart from Malaysia, Quadria Capital has
invested in various healthcare groups from Singapore
like MWH Holdings and Concord Biotech and are planning to expand more in the
near future. By this they slowly and steadily capture the Asian market,
maximize their returns and grow their equity firm in terms of value.
We firmly believe that our actions will
have an impact over the society and the way people live their lives. So, we
believe that addressing the environmental, social and governance is just only
the right thing to do, but important for sustainable and long-term value
creation.
Our other focus zones beside being a
regional leader in the Asian market, we also need to have a strong stable free cash flow, then
should have experienced and qualified management team who understands the
regional problems and provide quick solutions.
We would like to continue like this in
future and help in building the society and creating positive social impacts.
Our reputation as an individual and as a firm is our key to success.
We immensely value the support of our
investors and remain focused, and driven, to reward and repay their trust in
Quadria Capital.
Comments
Post a Comment